Barbara Fallowfield, Commercial Manager of Mologic was recently interviewed by Anna Macdonald of Technology Networks where they discussed issues clinicians face whilst under pressure to prescribe antibiotics, and how a recent partnership between Fraunhofer UK, and Mologic can help tackle those issues through the development of a novel in vitro diagnostic assay. This assay will provide assistance in accurately treating urinary tract infections, thereby helping to extend the life of current and future antibiotics.

It starts: "Antimicrobial resistance (AMR) is a growing concern to public health, threatening to make surgery, chemotherapy, and treatment to many infections no longer viable."
More details on our blog:

Full text of the article can be read at Technology Networks at: